• Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

  • Sep 24 2020
  • Duración: 47 m
  • Podcast

Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger  Por  arte de portada

Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

  • Resumen

  • Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.